Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.3B | 8.9B | 8.1B | 8.2B |
Cost of revenue | 7.9B | 7.3B | 6.2B | 6.6B |
Gross profit | 2.4B | 1.6B | 1.8B | 1.6B |
Operating expense | ||||
Research & development | 149.9M | 201.3M | 159.0M | 163.2M |
Selling general and admin | 617.2M | 832.0M | 689.7M | 642.6M |
Other operating expenses | — | — | — | — |
Operating income | 1.7B | 577.8M | 999.6M | 782.4M |
Non operating interest income | ||||
Income | 5.1M | 15.0M | 8.2M | 17.6M |
Expense | 4.5M | 4.9M | 3.5M | 5.4M |
Other income expense | — | — | — | — |
Pretax income | 1.6B | 581.4M | 881.4M | 999.1M |
Tax provision | 330.9M | 120.0M | 151.2M | 261.1M |
Net income | 1.3B | 461.3M | 730.2M | 738.0M |
Basic EPS | 2.4 | — | 1.4 | 1.4 |
Diluted EPS | 2.3 | — | 1.4 | 1.4 |
Basic average shares | 520.4M | — | 520.3M | 519.8M |
Diluted average shares | 522.6M | — | 520.3M | 519.8M |
EBITDA | 1.8B | 782.3M | 1.1B | 1.2B |
Net income from continuing op. | 1.6B | 581.4M | 881.4M | 999.1M |
Minority interests | -28.5M | -25.0M | -27.8M | -31.1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |